BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 19667400)

  • 1. A human monoclonal antibody drug and target discovery platform for B-cell chronic lymphocytic leukemia based on allogeneic hematopoietic stem cell transplantation and phage display.
    Baskar S; Suschak JM; Samija I; Srinivasan R; Childs RW; Pavletic SZ; Bishop MR; Rader C
    Blood; 2009 Nov; 114(20):4494-502. PubMed ID: 19667400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Siglec-6 on Chronic Lymphocytic Leukemia Cells Is a Target for Post-Allogeneic Hematopoietic Stem Cell Transplantation Antibodies.
    Chang J; Peng H; Shaffer BC; Baskar S; Wecken IC; Cyr MG; Martinez GJ; Soden J; Freeth J; Wiestner A; Rader C
    Cancer Immunol Res; 2018 Sep; 6(9):1008-1013. PubMed ID: 29980538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral immune responses against the immature laminin receptor protein show prognostic significance in patients with chronic lymphocytic leukemia.
    Friedrichs B; Siegel S; Kloess M; Barsoum A; Coggin J; Rohrer J; Jakob I; Tiemann M; Heidorn K; Schulte C; Kabelitz D; Steinmann J; Schmitz N; Zeis M
    J Immunol; 2008 May; 180(9):6374-84. PubMed ID: 18424761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies selected from combinatorial libraries block a tumor antigen that plays a key role in immunomodulation.
    McWhirter JR; Kretz-Rommel A; Saven A; Maruyama T; Potter KN; Mockridge CI; Ravey EP; Qin F; Bowdish KS
    Proc Natl Acad Sci U S A; 2006 Jan; 103(4):1041-6. PubMed ID: 16418292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CLL B-cell receptors can recognize themselves: alternative epitopes and structural clues for autostimulatory mechanisms in CLL.
    Binder M; Müller F; Frick M; Wehr C; Simon F; Leistler B; Veelken H; Mertelsmann R; Trepel M
    Blood; 2013 Jan; 121(1):239-41. PubMed ID: 23287626
    [No Abstract]   [Full Text] [Related]  

  • 6. Excessive antigen reactivity may underlie the clinical aggressiveness of chronic lymphocytic leukemia stereotyped subset #8.
    Gounari M; Ntoufa S; Apollonio B; Papakonstantinou N; Ponzoni M; Chu CC; Rossi D; Gaidano G; Chiorazzi N; Stamatopoulos K; Ghia P
    Blood; 2015 Jun; 125(23):3580-7. PubMed ID: 25900981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of structurally defined epitopes recognized by monoclonal antibodies produced by chronic lymphocytic leukemia B cells.
    Seiler T; Woelfle M; Yancopoulos S; Catera R; Li W; Hatzi K; Moreno C; Torres M; Paul S; Dohner H; Stilgenbauer S; Kaufman MS; Kolitz JE; Allen SL; Rai KR; Chu CC; Chiorazzi N
    Blood; 2009 Oct; 114(17):3615-24. PubMed ID: 19690339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of tumor-reactive T cells after nonmyeloablative allogeneic hematopoietic stem cell transplant for chronic lymphocytic leukemia.
    Nishida T; Hudecek M; Kostic A; Bleakley M; Warren EH; Maloney D; Storb R; Riddell SR
    Clin Cancer Res; 2009 Jul; 15(14):4759-68. PubMed ID: 19567591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broad alterations of self-reactive antibody-repertoires of plasma IgM and IgG in B-cell chronic lymphocytic leukemia (B-CLL) and B-CLL related target-restricted autoimmunity.
    Stahl D; Lacroix-Desmazes S; Sibrowski W; Kazatchkine MD; Kaveri SV
    Leuk Lymphoma; 2001 Jun; 42(1-2):163-76. PubMed ID: 11699204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGHV1-69 B cell chronic lymphocytic leukemia antibodies cross-react with HIV-1 and hepatitis C virus antigens as well as intestinal commensal bacteria.
    Hwang KK; Trama AM; Kozink DM; Chen X; Wiehe K; Cooper AJ; Xia SM; Wang M; Marshall DJ; Whitesides J; Alam M; Tomaras GD; Allen SL; Rai KR; McKeating J; Catera R; Yan XJ; Chu CC; Kelsoe G; Liao HX; Chiorazzi N; Haynes BF
    PLoS One; 2014; 9(3):e90725. PubMed ID: 24614505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Four ricin chain A-based immunotoxins directed against the common chronic lymphocytic leukemia antigen: in vitro characterization.
    Faguet GB; Agee JF
    Blood; 1993 Jul; 82(2):536-43. PubMed ID: 7687163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease.
    Brudno JN; Somerville RP; Shi V; Rose JJ; Halverson DC; Fowler DH; Gea-Banacloche JC; Pavletic SZ; Hickstein DD; Lu TL; Feldman SA; Iwamoto AT; Kurlander R; Maric I; Goy A; Hansen BG; Wilder JS; Blacklock-Schuver B; Hakim FT; Rosenberg SA; Gress RE; Kochenderfer JN
    J Clin Oncol; 2016 Apr; 34(10):1112-21. PubMed ID: 26811520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning, isolation and characterization of human tumor in situ monoclonal antibodies.
    Wu H; Pancook JD; Beuerlein G; Chilton T; Pecht G; Huse WD; Watkins JD
    Cancer Immunol Immunother; 2002 Apr; 51(2):79-90. PubMed ID: 11904732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
    Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
    Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptides that bind specifically to an antibody from a chronic lymphocytic leukemia clone expressing unmutated immunoglobulin variable region genes.
    Liu Y; Higgins CD; Overstreet CM; Rai KR; Chiorazzi N; Lai JR
    Mol Med; 2013 Aug; 19(1):245-52. PubMed ID: 23922242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of human Fab libraries for phage display.
    Rader C
    Methods Mol Biol; 2012; 901():53-79. PubMed ID: 22723094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural aspects of human IgM antibodies expressed in chronic B lymphocytic leukemia.
    Ramsland PA; Brock CR; Moses J; Robinson BG; Edmundson AB; Raison RL
    Immunotechnology; 1999 Mar; 4(3-4):217-29. PubMed ID: 10231091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies.
    Lanemo Myhrinder A; Hellqvist E; Sidorova E; Söderberg A; Baxendale H; Dahle C; Willander K; Tobin G; Bäckman E; Söderberg O; Rosenquist R; Hörkkö S; Rosén A
    Blood; 2008 Apr; 111(7):3838-48. PubMed ID: 18223168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation and selection of immunized Fab phage display library against human B cell lymphoma.
    Shen Y; Yang X; Dong N; Xie X; Bai X; Shi Y
    Cell Res; 2007 Jul; 17(7):650-60. PubMed ID: 17621306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of human Fab libraries by phage display.
    Rader C
    Methods Mol Biol; 2012; 901():81-99. PubMed ID: 22723095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.